RXRA and preeclampsia: In addition, the overexpression of IL-17 has been reported to promote the proliferation, migration, and invasion of trophoblast cells by regulating the PPAR-α/RXR-α/Wnt signaling pathway; therefore, IL-17 may be a potential therapeutic target for preeclampsia (Zhang et al., 2022).